BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Authors » Cormac Sheridan

Cormac Sheridan

Articles

ARTICLES

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 25, 2002
By Cormac Sheridan

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 24, 2002
By Cormac Sheridan

Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin

Sep. 24, 2002
By Cormac Sheridan

Actelion Moving Tezosentan Into Phase III For Acute Heart Failure

Sep. 18, 2002
By Cormac Sheridan

Lund University Establishing Stem Cell Research Institute

Sep. 18, 2002
By Cormac Sheridan

GPCRs Focus Of Deals Involving Biovitrium, BioFocus, BioXell

Sep. 18, 2002
By Cormac Sheridan
G protein-coupled receptors, the superfamily of membrane-spanning proteins involved in diverse signaling processes, are the subject of two drug discovery collaborations unveiled last week by European biotechnology firms. (BioWorld International)
Read More

Lund University Establishing Stem Cell Research Institute

Sep. 18, 2002
By Cormac Sheridan

GPCRs Focus Of Deals Involving Biovitrium, BioFocus, BioXell

Sep. 18, 2002
By Cormac Sheridan
G protein-coupled receptors, the superfamily of membrane-spanning proteins involved in diverse signaling processes, are the subject of two drug discovery collaborations unveiled last week by European biotechnology firms. (BioWorld International)
Read More

Actelion Moving Tezosentan Into Phase III For Acute Heart Failure

Sep. 18, 2002
By Cormac Sheridan

Medivir To Lose CEO Frick To Venture Capital Fund

Sep. 11, 2002
By Cormac Sheridan
View All Articles by Cormac Sheridan

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • DNA, dollars illustration

    Latus Bio series A financing supports early-stage programs

    BioWorld Science

    Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing